Days alive and out of hospital after treatment for oropharyngeal squamous cell carcinoma with primary transoral robotic surgery or radiotherapy – a prospective cohort study

Abstract

DAOH has not been examined in oropharyngeal cancer before. We found, patients overall spent 92.5% of the first 180 days alive and out of hospital. Patients treated with TORS had high DAOH₃₀, which remained high in DAOH₁₈₀, while patients treated with RT with reduced DAOH₃₀, had reduced DAOH₁₈₀ calling for further large-scale studies.